ISB News

Dr. Wei Wei Awarded CARE Grant

The Andy Hill Cancer Research Endowment (CARE) announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.

“I am extremely honored. This is an unforgettable moment that is much bigger than me — it would not have been possible without the support of my team members, my colleagues, and my institution,” said Wei. “The award recognizes successes of the past and the promise of the future. With the generous support of the CARE fund, I will do everything I can to fight cancer.”

The Wei Lab is developing micro technologies that cultivate new understandings in fundamental cancer biology, as well as new opportunities in translational research in the clinic.

Wei is the second ISB researcher to receive grant funding distinguished researcher funding from The Andy Hill CARE Fund, a public-private partnership that supports cancer research in Washington state. ISB President Dr. Jim Heath was awarded $500,000 in December 2017.

Wei joined ISB in August. Prior to coming to Seattle, he earned his PhD from Caltech and served as a faculty member at UCLA Medical School.

Read a recent Q&A with Wei that delves into his research career, how research might change over the next decade, and his interests and hobbies when not focusing on science.

Related Articles

  • New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines

    Members of ISB’s Heath Lab and their collaborators have developed a way to sensitively detect and analyze neoantigen-specific T-cell populations from tumors and blood. This promising development may have implications for creating targeted, individual-specific cancer vaccines.

  • New Diagnostic Method Predicts Therapy Response in Lung Cancer Patients

    By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer (NSCLC) patients, ISB researchers and their collaborators can accurately predict how patients will respond to various cancer therapies, and how treatments will impact a patient’s physiological performance and survival.

  • The Cancer Paradox

    ISB’s Dr. Sui Huang uses the theory of complex systems and applies it to cancer research. In this video Q&A, he discusses the cancer paradox and highlights the importance of understanding the mechanism of what cancer treatments can backfire in order to open a new avenue for therapy and treatments.

Show More Articles